🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry

Recruitingn/aAges any - anyAllJohannes Gutenberg University Mainz
NCT02180178 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Primary goal of the registry is to collect prospective data on patients undergoing coronary angiography in Mainz. Following amendment of the procol, this study will also include patients who received an Aborb bioresorbable scaffold for the therapy of de novo stenoses.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * clinical indication to coronary angiography Exclusion Criteria: * none
💊

What it tests

  • observational only- no intervention
📍

Where

1 site
University Medical Center Mainz - 2 Medizinische Klinik
Mainz, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy